New Delhi: The government is in talks with Johnson & Johnson about their single dose vaccine and according to plan, this vaccine will also be produced by biologically Hyderabad, Niti Aayog Members-Health Dr.
V K Paul.
This vaccine shows strong neutralization antibody activity against the Delta variant (B16172), with immunity lasts at least eight months, according to pre-printed phase-III trial results.
Johnson & Johnson has been announced on Thursday that the Covid-19 vaccine of his single-shot shows signs of promising protection against Delta variants quickly spread throughout the US and other countries.
According to a company report, this vaccine produces strong and persistent activities to the Delta variant which spreads rapidly and the Virus variant of the SARS-COV-2 is very prevalent.
In addition, the data shows that the immune response resistance takes place at least eight months, the length of time is evaluated to date.
Two summaries of Prefrint studies have been submitted to Biorxiv, a non-profit prefrint server for life science.
Covid-19: The government talks with J & J above a single dose jab
